Other

Dataset Information

0

Cell-based models of ‘Cytokine Release Syndrome’ endorse CD40L and GM-CSF knockout in CAR T cells as mitigation strategy


ABSTRACT: Chimeric antigen receptor (CAR) T cells are engineered lymphocytes able to recognize and eradicate cancer cells. While CAR T cell therapy has shown promising outcomes in patients with hematologic malignancies, it can cause undesirable side-effects such as cytokine release syndrome (CRS). CRS is triggered by CAR T cell-based activation of monocytes, which are stimulated via the CD40L–CD40R axis or via uptake of GM-CSF to secrete pro-inflammatory cytokines. Mouse models have been used to model CRS but they are labor intensive and not amenable to screening approaches. To overcome this challenge, we established two cell-based CRS in vitro models that entail the co-culturing of leukemic B cells with CD19-targeting CAR T cells and primary monocytes from the same donor. Upon antigen encounter, CAR T cells upregulated CD40L and GM-CSF which stimulated the monocytes to release IL-6. To endorse these models, we demonstrated that neutralizing antibodies or genetic disruption of the CD40L and/or CSF2 loci in CAR T cells using CRISPR-Cas technology significantly reduced IL-6 secretion by bystander monocytes without affecting the cytolytic activity of the engineered lymphocytes. Overall, our cell-based models were able to recapitulate CRS in vitro, allowing us to validate mitigation strategies based on antibodies or genome editing.

ORGANISM(S): Homo sapiens

PROVIDER: GSE243587 | GEO | 2023/12/06

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-12-06 | GSE186449 | GEO
2017-02-21 | E-MTAB-5412 | biostudies-arrayexpress
2017-02-21 | E-MTAB-5414 | biostudies-arrayexpress
2014-11-27 | E-GEOD-63662 | biostudies-arrayexpress
2014-11-27 | GSE63662 | GEO
2012-05-20 | E-GEOD-37029 | biostudies-arrayexpress
2019-09-12 | GSE123573 | GEO
2019-09-12 | GSE123569 | GEO
2019-09-12 | GSE123270 | GEO
2019-09-13 | GSE123268 | GEO